...
机译:在儿科患者中检测剂量药代动力学接受造血干细胞移植一次每日IV母鹅调理:一种可靠的方法?
Clinical Pharmacokinetics Research UnitNational Institutes of HealthBethesda MD USA;
Clinical Center Pharmacy DepartmentNational Institutes of HealthBethesda MD USA;
Clinical Center Pharmacy DepartmentNational Institutes of HealthBethesda MD USA;
Genetic Immunotherapy Section National Institute of Allergy and Infectious DiseasesNational;
Pediatric Oncology BranchNational Institutes of HealthBethesda MD USA;
Pediatric Oncology BranchNational Institutes of HealthBethesda MD USA;
Experimental Transplantation &
Immunology BranchNational Institutes of HealthBethesda MD USA;
Genetic Immunotherapy Section National Institute of Allergy and Infectious DiseasesNational;
Clinical Pharmacokinetics Research UnitNational Institutes of HealthBethesda MD USA;
Clinical Pharmacokinetics Research UnitNational Institutes of HealthBethesda MD USA;
busulfan; therapeutic drug monitoring; test dose; pharmacokinetics; pediatrics;
机译:在儿科患者中检测剂量药代动力学接受造血干细胞移植一次每日IV母鹅调理:一种可靠的方法?
机译:在接受测试剂量的造血干细胞移植患者中使用个体化口服白硫丹剂量:药代动力学表征
机译:接受造血干细胞移植的儿科患者可以大大受益于一次每日一日静脉内的Busulfan给药墨水图
机译:静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
机译:接受同种异体造血干细胞移植的患者的供体选择:加拿大造血干细胞移植医生的优先事项评估。
机译:在接受每日一次白消安调理用于造血干细胞移植的小儿患者的测试剂量药代动力学:一种可靠的方法?
机译:472:用于异体造血干细胞移植的药代动力学研究,移植前白消安试验剂量是第一个白消安IV剂量的可靠替代品